De novo p.Arg756Cys mutation of ATP1A3 causes an atypical form of alternating hemiplegia of childhood with prolonged paralysis and choreoathetosis

التفاصيل البيبلوغرافية
العنوان: De novo p.Arg756Cys mutation of ATP1A3 causes an atypical form of alternating hemiplegia of childhood with prolonged paralysis and choreoathetosis
المؤلفون: Yasunari Sakai, Hiroaki Ono, Yoshito Ishizaki, Ryoko Fukai, Hikaru Kanemasa, Hirotomo Saitsu, Masafumi Sanefuji, Naomichi Matsumoto, Toshiro Hara, Hiroyuki Torisu, Michiko Torio, Satoshi Akamine, Noriko Miyake, Sooyoung Lee, Kei Nishiyama
المصدر: BMC Neurology
سنة النشر: 2016
مصطلحات موضوعية: 0301 basic medicine, Male, Pathology, medicine.medical_specialty, Areflexia, Clinical Neurology, Choreoathetosis, Hemiplegia, Case Report, Optic atrophy and sensorineural hearing loss, Neurological disorder, 03 medical and health sciences, 0302 clinical medicine, Chorea, ATP1A3, medicine, Paralysis, Humans, Child, Athetosis, Dystonia, Cerebellar ataxia, business.industry, Alternating hemiplegia of childhood, Rapid-onset dystonia-Parkinsonism, General Medicine, medicine.disease, Hypotonia, 030104 developmental biology, Phenotype, Whole-exome sequencing, Mutation, Neurology (clinical), medicine.symptom, Sodium-Potassium-Exchanging ATPase, business, Neuroscience, 030217 neurology & neurosurgery
الوصف: Background Alternating hemiplegia of childhood (AHC) is a rare neurological disorder that manifests recurrent attacks of hemiplegia, oculogyric, and choreoathetotic involuntary movements. De novo mutations in ATP1A3 cause three types of neurological diseases: AHC; rapid-onset dystonia-Parkinsonism (RDP); and cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS) syndromes. It remains to be determined whether or not a rare mutation in ATP1A3 may cause atypical phenotypes. Case presentation A 7-year-old boy presented with recurrent symptoms of generalized paralysis since 1 year and 5 months of age. Hypotonia, dystonia, and choreoathetosis persisted with exacerbation under febrile conditions, but no cerebellar ataxia had ever evolved in 6 years. Whole-exome sequencing (WES) was performed to determine his genetic background, and mutations were validated by the Sanger method. Crude protein extracts were prepared from the cultured cells, and expression of the wild-type or mutant ATP1A3 proteins were analyzed by Western blotting. WES identified a de novo pathogenic mutation in ATP1A3 (c.2266C > T:p.R756C) for this patient. A literature overview of two reported cases with p.R756C and p.R756H mutations showed both overlapping and distinct phenotypes when compared with those of the present case. The expression of the mutant form (R756C) of ATP1A3 did not differ markedly from that of the wild-type and D801N proteins. Conclusions This study confirmed that p.R756C mutation of ATP1A3 cause atypical forms of AHC-associated disorders. The wide spectra of neurological phenotypes in AHC are linked to as-yet-unknown deficits in the functions of mutant ATP1A3. Electronic supplementary material The online version of this article (doi:10.1186/s12883-016-0680-6) contains supplementary material, which is available to authorized users.
تدمد: 1471-2377
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0df8eb0cd6aaaa4658d046fbebd6c78f
https://pubmed.ncbi.nlm.nih.gov/27634470
Rights: OPEN
رقم الانضمام: edsair.doi.dedup.....0df8eb0cd6aaaa4658d046fbebd6c78f
قاعدة البيانات: OpenAIRE